copy of dr. adams on whether prior lines of therapy impact response to immunotherapy in tnbc
Published 6 years ago • 19 plays • Length 0:20Download video MP4
Download video MP3
Similar videos
-
1:20
dr. adams on whether prior lines of therapy impact response to immunotherapy in tnbc
-
0:26
copy of dr. adams on immunotherapy in triple-negative breast cancer
-
1:49
dr. adams on combinatorial approaches in triple-negative breast cancer
-
2:08
dr. adams on immunotherapy in triple-negative breast cancer
-
5:49
immunotherapy for tnbc
-
34:50
breast cancer immunotherapy with dr. sylvia adams and victor ty, bsn, rn
-
31:24
harnessing the immune system in the treatment of triple-negative breast cancer
-
1:33
dr. sylvia adams on tumor-infiltrating lymphocytes in triple negative breast cancer
-
6:01
immunotherapy for triple-negative breast cancer
-
1:59
dr. andreopoulou on the impact of immunotherapy in tnbc
-
21:00
precision medicine in metastatic triple negative breast cancer
-
2:10
dr. sherwell-cabello on prognostic impact of tils and sils in tnbc
-
8:32
immunotherapy for triple-negative breast cancer
-
10:14
asco: pembrolizumab plus chemotherapy for advanced triple-negative breast cancer
-
7:20
ar-targeted therapy and immunotherapy for tnbc
-
0:25
copy of dr. mehta on immunotherapy in gastric/gej cancer
-
1:04:28
harnessing the immune system in the treatment of triple-negative breast cancer
-
0:57
dr. bardia on the role of the microenvironment in tnbc
-
1:17
dr. hamilton on fda approval of atezolizumab/nab-paclitaxel in tnbc